Cite

    Kaku, K. et al. (n.d.). Efficacy and safety of pioglitazone added to alogliptin in Japanese patients with type 2 diabetes mellitus: a multicentre, randomized, double‐blind, parallel‐group, comparative study. Diabetes, obesity & metabolism. 17 (12), pp. 1198-1201. [Online].